CelLBxHealth plc (LON:CLBX)
1.63p+7.17%
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Auditors flag survival doubt; AstraZeneca deal offers hope but cash burns fast.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About CelLBxHealth plc
CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTC…
- Sector:
- Healthcare
- Industry:
- Diagnostics & Research
- Market Cap:
- £29.6M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across CelLBxHealth plc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free